2021 年 38 巻 4 号 p. 495-498
Hypoglossal nerve stimulation (HNS) is a novel therapy in treating moderate and severe obstructive sleep apnea (OSA) in patients who cannot tolerate continuous positive airway pressure (CPAP) therapy. Studies showed that HNS decreased apnea–hypopnea index decreased by 68%, and that the device was effective even after five years. HNS has become a therapeutic option for OSA. More studies may be needed to ensure the highest safety profile.